Antibiotic resistance has emerged as a major public health threat. Patients infected with drug- resistant pathogens suffer significantly higher rates o morbidity and mortality, most often due to delays in the administration of effective antimicrobial therapies. In particular for bloodstream infections, the need to rapidly identify both pathogen and resistance profile is crucial, as treatment with antibiotics to which the organism is sensitive is essential and time-critical. Indeed, sepsis is involved in up to half of all hospital deaths. Drug susceptibility information for a pathogen is typically not received by clinicians until at least 24 hours post-sampling, because of reliance on culture-based diagnostic methods. Recently, bloodstream infections caused by carbapenem-resistant Enterobacteriaceae (CRE) have become increasingly problematic. A rapid diagnostic assay for the detection and resistance determination of these pathogens is urgently needed. Although PCR-based assays are rapid, specific, and amenable to multiplexing, they have largely failed to perform in blood samples. Our industrial partner, Great Basin Corporation, has developed a fully disposable cartridge system for pathogen detection in cultured blood. We propose major improvements to this platform through the development of a multiplexed, non-amplified, non-cultured, nucleic acid-based assay for the detection and identification of multidrug resistant pathogens using a novel integrated optofluidic device. Bacteria will be concentrated directly from a blood sample by cross-flow filtration, and then delivered to a lysis and DNA-shearing chamber. Target DNAs containing the genes of interest will be captured on a solid substrate by hybridization. Molecular beacons will be hybridized to specific targets on the captured nucleic acids. These complexes will be released and specific beacons detected by an advanced optofluidics system capable of detecting single molecule fluorescence. We will demonstrate identification within one hour of bacteria in blood at levels as low as 10 CFU/mL. Initially, the focus will be to detect and characterize CRE isolated directly from a blood sample. The KPC, NDM, VIM, and IMP carbapenemase genes will be identified along with the simultaneous detection of specific markers for Klebsiella pneumoniae, Escherichia coli, and Enterobacter species. This platform is readily expandable to additional pathogens and their relevant antibiotic resistance genes. This technology has the potential to significantly reduce time to diagnosis and improve clinical outcomes.

Public Health Relevance

The rising prevalence of antibiotic resistance in bacteria is a significant threat to public health. Infections with these bacteria are particularly dangerous because patients often die before they receive effective treatment. Current methods used to diagnose the cause and determine effective treatment strategies for bacterial infections of the blood are slow, and the infection often worsens while doctors wait for results. There is an urgent need for tests that will identify the bacteria causing a serious infection and the antibiotics to which these bacteria are resistant, and do so within 1 hour. This project describes the development of such a test.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI116989-01
Application #
8875203
Study Section
Special Emphasis Panel (ZAI1-MFH-M (J1))
Program Officer
Ritchie, Alec
Project Start
2015-03-01
Project End
2020-02-28
Budget Start
2015-03-01
Budget End
2016-02-29
Support Year
1
Fiscal Year
2015
Total Cost
$1,383,090
Indirect Cost
$275,674
Name
Brigham Young University
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
009094012
City
Provo
State
UT
Country
United States
Zip Code
84602
Knob, Radim; Hanson, Robert L; Tateoka, Olivia B et al. (2018) Sequence-specific sepsis-related DNA capture and fluorescent labeling in monoliths prepared by single-step photopolymerization in microfluidic devices. J Chromatogr A 1562:12-18
Stott, Matthew A; Ganjalizadeh, Vahid; Olsen, Maclain et al. (2018) Optimized ARROW-Based MMI Waveguides for High Fidelity Excitation Patterns for Optofluidic Multiplexing. IEEE J Quantum Electron 54:
Black, Jennifer A; Ganjalizadeh, Vahid; Parks, Joshua W et al. (2018) Multi-channel velocity multiplexing of single virus detection on an optofluidic chip. Opt Lett 43:4425-4428
Meena, Gopikrishnan G; Jain, Aadhar; Parks, Joshua W et al. (2018) Integration of sample preparation and analysis into an optofluidic chip for multi-target disease detection. Lab Chip 18:3678-3686
Wall, Thomas; Hammon, Steven; Hamilton, Erik et al. (2017) Mitigating Water Absorption in Waveguides Made From Unannealed PECVD SiO2. IEEE Photonics Technol Lett 29:806-809
Knob, Radim; Nelson, Daniel B; Robison, Richard A et al. (2017) Sequence-specific DNA solid-phase extraction in an on-chip monolith: Towards detection of antibiotic resistance genes. J Chromatogr A 1523:309-315
Buchanan, Clara M; Wood, Ryan L; Hoj, Taalin R et al. (2017) Rapid separation of very low concentrations of bacteria from blood. J Microbiol Methods 139:48-53
Wall, Thomas; McMurray, Johnny; Meena, Gopikrishnan et al. (2017) Optofluidic Lab-on-a-Chip Fluorescence Sensor Using Integrated Buried ARROW (bARROW) Waveguides. Micromachines (Basel) 8:
Alizadeh, Mahsa; Wood, Ryan L; Buchanan, Clara M et al. (2017) Rapid separation of bacteria from blood - Chemical aspects. Colloids Surf B Biointerfaces 154:365-372
Ozcelik, Damla; Cai, Hong; Leake, Kaelyn D et al. (2017) Optofluidic bioanalysis: fundamentals and applications. Nanophotonics 6:647-661

Showing the most recent 10 out of 20 publications